Sakata Taizo, Takahata Takaomi, Kimura Toshikazu, Yasuhara Isao, Kojima Toru, Akazai Yoshihiro, Mimura Tetsushige, Lefor Alan Kawarai
Department of Surgery, Okayama Saiseikai General Hospital, Okayama, Japan.
Department of Surgery, Jichi Medical University, Tochigi, Japan.
Ann Med Surg (Lond). 2019 Jan 30;39:10-15. doi: 10.1016/j.amsu.2019.01.003. eCollection 2019 Mar.
Peritoneal dissemination of gastric cancer is often associated with serosal infiltration. The aim of this study was to evaluate the clinical importance of peritoneal lavage cytology in patients with gastric carcinoma without serosal invasion. The incidence and impact on prognosis of positive cytology were analyzed.
Of 2768 patients with gastric cancer, outcomes and pathological characteristics of 973 patients were reviewed retrospectively. All patients underwent peritoneal lavage at laparotomy for curative or palliative resection of gastric cancer between 1999 and 2017. Among these, 479 who underwent surgery from January 1999 to March 2012 were also reviewed to analyze 5-year survival.
Of 973 patients enrolled, 338 (35%) did not have serosal invasion, and peritoneal cytology was positive in 4/338 (1.2%). Of these four patients, one had submucosal invasion and three had muscularis propria invasion. Of 635 patients with serosal invasion, peritoneal cytology was positive in 74/635 (12%). Of 479 patients reviewed for survival, cytology was positive in 32/479, with 3/32 (9%) surviving for five years, and cytology was negative in 447 patients with 266/447 (60%) surviving for five years.
Cytologic evaluation should be routinely performed in patients with early-stage gastric cancer.
胃癌的腹膜播散常与浆膜浸润相关。本研究旨在评估腹膜灌洗细胞学检查在无浆膜侵犯的胃癌患者中的临床重要性。分析了阳性细胞学检查的发生率及其对预后的影响。
回顾性分析2768例胃癌患者中973例的结局和病理特征。1999年至2017年间,所有患者在剖腹手术时均接受了腹膜灌洗,以进行胃癌的根治性或姑息性切除。其中,对1999年1月至2012年3月接受手术的479例患者也进行了回顾,以分析其5年生存率。
在纳入的973例患者中,338例(35%)无浆膜侵犯,其中4/338例(1.2%)腹膜细胞学检查呈阳性。在这4例患者中,1例有黏膜下侵犯,3例有固有肌层侵犯。在635例有浆膜侵犯的患者中,74/635例(12%)腹膜细胞学检查呈阳性。在接受生存分析的479例患者中,32/479例细胞学检查呈阳性,其中3/32例(9%)存活5年;447例细胞学检查呈阴性的患者中,266/447例(60%)存活5年。
早期胃癌患者应常规进行细胞学评估。